Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Peptic Ulcer

  Free Subscription

Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 100 articles:
HTML format

Single Articles

    July 2021
  1. CHO JH, Jin SY, Park S
    Scoring model for discriminating gastric cancer risk in patients with negative serum pepsinogen and anti-Helicobacter pylori antibody results.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15630.
    PubMed     Abstract available

  2. CHEN Y, Xu C, Xu H, Chen W, et al
    Persistent Helicobacter pylori infection for more than 3 years leads to elevated serum homocysteine concentration: a retrospective cohort study based on a healthy Chinese population.
    J Gastroenterol Hepatol. 2021 Jul 1. doi: 10.1111/jgh.15603.
    PubMed     Abstract available

  3. SUNG JJ
    Clopidogrel is no better or worse than aspirin when combined with proton pump inhibitors in the prevention of major adverse event. Is the jury out?
    J Gastroenterol Hepatol. 2021;36:1733-1734.

    June 2021
  4. HUSSEIN M, Alzoubaidi D, O'Donnell M, de la Serna A, et al
    Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes.
    J Gastroenterol Hepatol. 2021 Jun 15. doi: 10.1111/jgh.15579.
    PubMed     Abstract available

  5. GINGOLD-BELFER R, Niv Y, Schmilovitz-Weiss H, Levi Z, et al
    Susceptibility-Guided vs Empirical Treatment for Helicobacter pylori infection: a Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2021 Jun 11. doi: 10.1111/jgh.15575.
    PubMed     Abstract available

  6. HORII T, Suzuki S, Takano C, Shibuya H, et al
    Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2021 Jun 9. doi: 10.1111/jgh.15572.
    PubMed     Abstract available

    May 2021
  7. JEON HJ, Moon HS, Kwon IS, Kang SH, et al
    Which scoring system should be used for non-variceal upper gastrointestinal bleeding? Old or New?
    J Gastroenterol Hepatol. 2021 May 24. doi: 10.1111/jgh.15555.
    PubMed     Abstract available

    March 2021
  8. QIAO C, Li Y, Liu J, Ji C, et al
    Clarithromycin versus furazolidone for naive Helicobacter pylori infected patients in a high clarithromycin resistance area.
    J Gastroenterol Hepatol. 2021 Mar 10. doi: 10.1111/jgh.15468.
    PubMed     Abstract available

  9. KODAMA M, Okimoto T, Mizukami K, Hirashita Y, et al
    Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: a long-term prospective follow-up study.
    J Gastroenterol Hepatol. 2021 Mar 3. doi: 10.1111/jgh.15477.
    PubMed     Abstract available

    February 2021
  10. AKADA J, Tshibangu-Kabamba E, Tuan VP, Kurogi S, et al
    Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay.
    J Gastroenterol Hepatol. 2021 Feb 20. doi: 10.1111/jgh.15467.
    PubMed     Abstract available

    January 2021
  11. KATO M, Hayashi Y, Nishida T, Oshita M, et al
    Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis.
    J Gastroenterol Hepatol. 2021 Jan 5. doi: 10.1111/jgh.15396.
    PubMed     Abstract available

  12. NIIKURA R, Aoki T, Kojima T, Kawahara T, et al
    Natural history of upper and lower gastrointestinal bleeding in hemodialysis patients: A dual-center long-term cohort study.
    J Gastroenterol Hepatol. 2021;36:112-117.
    PubMed     Abstract available

    November 2020
  13. YANG SC, Wu CK, Tai WC, Liang CM, et al
    Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding.
    J Gastroenterol Hepatol. 2020 Nov 28. doi: 10.1111/jgh.15360.
    PubMed     Abstract available

  14. SCHUBERT JP, Gehlert J, Rayner CK, Roberts-Thomson IC, et al
    Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis.
    J Gastroenterol Hepatol. 2020 Nov 20. doi: 10.1111/jgh.15352.
    PubMed     Abstract available

    October 2020
  15. GINGOLD-BELFER R, Niv Y, Levi Z, Boltin D, et al
    Rifabutin triple therapy for first-line and rescue treatment of Helicobacter pylori infection: a systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2020 Oct 10. doi: 10.1111/jgh.15294.
    PubMed     Abstract available

  16. TANG C, Zhu Y, Yang X, Xu B, et al
    Upper gastrointestinal mucosal injury associated with ticagrelor plus aspirin, ticagrelor alone, or aspirin alone at 1-year after coronary artery bypass grafting.
    J Gastroenterol Hepatol. 2020;35:1720-1730.
    PubMed     Abstract available

    September 2020
  17. GRAHAM DY, Lu H, Shiotani A
    Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
    J Gastroenterol Hepatol. 2020 Sep 12. doi: 10.1111/jgh.15252.
    PubMed     Abstract available

  18. PYO JH, Kim TJ, Lee H, Choi SC, et al
    Proton Pump Inhibitors Use and the Risk of Fatty Liver Disease; A Nationwide Cohort Study.
    J Gastroenterol Hepatol. 2020 Sep 4. doi: 10.1111/jgh.15236.
    PubMed     Abstract available

    August 2020
  19. LI ZX, Ma JL, Guo Y, Liu WD, et al
    Suppression of Helicobacter pylori Infection by Daily Cranberry Intake: A Double-Blind, Randomized, Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2020 Aug 11. doi: 10.1111/jgh.15212.
    PubMed     Abstract available

    July 2020
  20. CHIANG TH, Maeda M, Yamada H, Chan CC, et al
    Risk Stratification for Gastric Cancer after Helicobacter pylori Eradication: A Population-based Study on Matsu Islands.
    J Gastroenterol Hepatol. 2020 Jul 15. doi: 10.1111/jgh.15187.
    PubMed     Abstract available

  21. KIM TJ, Lee H, Min YW, Min BH, et al
    Cohort Study of Helicobacter Pylori Infection and the Risk of Incident Osteoporosis in Women.
    J Gastroenterol Hepatol. 2020 Jul 13. doi: 10.1111/jgh.15181.
    PubMed     Abstract available

  22. KONO Y, Kusumoto C, Kiguchi T, Okada H, et al
    Gastrointestinal: Rapid emergence of double-expressor lymphoma after Helicobacter pylori eradication therapy.
    J Gastroenterol Hepatol. 2020 Jul 9. doi: 10.1111/jgh.15162.

    June 2020
  23. CHEN G, Ning LJ, Qin Y, Zhao B, et al
    Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    J Gastroenterol Hepatol. 2020 Jun 15. doi: 10.1111/jgh.15151.
    PubMed     Abstract available

  24. WONG SH, Yu J
    Proton-pump inhibitor use before fecal microbiota transplant: A wonder drug, a necessary evil, or a needless prescription?
    J Gastroenterol Hepatol. 2020;35:913-914.

    May 2020
  25. ZHENG Y, Xue M, Cai Y, Liao S, et al
    Hospitalizations for Peptic Ulcer Disease in China: Current Features and Outcomes.
    J Gastroenterol Hepatol. 2020 May 25. doi: 10.1111/jgh.15119.
    PubMed     Abstract available

  26. LIN XH, Luo JC, Ting PH, Chang TE, et al
    Comparison of the efficiency of two different proton pump inhibitor formula in treatment of patients with atypical gastroesophageal reflux disease: a prospective randomized study.
    J Gastroenterol Hepatol. 2020 May 13. doi: 10.1111/jgh.15093.
    PubMed     Abstract available

  27. LIN JT
    Reducing the health disparity in gastric cancer: A start by Helicobacter pylori eradication in indigenous peoples living in Taiwan.
    J Gastroenterol Hepatol. 2020;35:705-706.

    April 2020
  28. SUNG JJY
    Population-based screening and mass eradication of Helicobacter pylori infection to prevent gastric cancer: There are more questions than answers.
    J Gastroenterol Hepatol. 2020;35:521-522.

    February 2020
  29. NOH G, Kim N, Choi Y, Lee HS, et al
    Long-term follow-up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2020 Feb 23. doi: 10.1111/jgh.15017.
    PubMed     Abstract available

  30. NAM JH, Nam SY, Park BJ, Ryu KH, et al
    Effect of Helicobacter pylori Infection and its Eradication on Gastric Regenerating Atypia in 22,133 Subjects.
    J Gastroenterol Hepatol. 2020 Feb 21. doi: 10.1111/jgh.15016.
    PubMed     Abstract available

    January 2020
  31. LIOU JM, Lee YC, Wu MS
    Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota.
    J Gastroenterol Hepatol. 2020 Jan 26. doi: 10.1111/jgh.14992.
    PubMed     Abstract available

  32. IN SEO S, You SC, Park CH, Kim TJ, et al
    Comparative Risk of Clostridium difficile Infection between Proton Pump Inhibitors and Histamine-2 Receptor Antagonists: A 15-year Hospital Cohort Study Using a Common Data Model.
    J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14983.
    PubMed     Abstract available

  33. YIN G, Bie S, Gu H, Shu X, et al
    Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children.
    J Gastroenterol Hepatol. 2020 Jan 12. doi: 10.1111/jgh.14980.
    PubMed     Abstract available

  34. SHUNG DL, Sung JJY
    A new scoring system for upper gastrointestinal bleeding: Too simple or still complicated?
    J Gastroenterol Hepatol. 2020;35:5.

    December 2019
  35. HONG AS, Yu WY, Hong JM, Cross CL, et al
    J Gastroenterol Hepatol. 2019 Dec 12. doi: 10.1111/jgh.14958.
    PubMed     Abstract available

  36. DU Y, Zhu H, Liu J, Li J, et al
    Consensus on eradication of Helicobacter pylori and prevention & control of gastric cancer in China (2019, Shanghai).
    J Gastroenterol Hepatol. 2019 Dec 1. doi: 10.1111/jgh.14947.
    PubMed     Abstract available

    November 2019
  37. MYINT NPST, Zaw TT, Sain K, Waiyan S, et al
    Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability.
    J Gastroenterol Hepatol. 2019 Nov 23. doi: 10.1111/jgh.14942.
    PubMed     Abstract available

  38. NOTSU T, Adachi K, Mishiro T, Ishimura N, et al
    Fundic gland polyp prevalence according to Helicobacter pylori infection status.
    J Gastroenterol Hepatol. 2019 Nov 16. doi: 10.1111/jgh.14934.
    PubMed     Abstract available

  39. WU CK, Yang SC, Liang CM, Li YC, et al
    The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis.
    J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14873.
    PubMed     Abstract available

  40. BAIR MJ, Chuang SL, Lei WY, Chen CL, et al
    Planning Mass Eradication of Helicobacter pylori Infection for Indigenous Taiwanese Peoples to Reduce Gastric Cancer.
    J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14898.
    PubMed     Abstract available

    August 2019
  41. ZHANG F, Wang F, Chen C, Wang T, et al
    CYP3A4 predicts progression of chronic atrophic gastritis with Helicobacter pylori and poor prognosis of gastric cancer.
    J Gastroenterol Hepatol. 2019 Aug 23. doi: 10.1111/jgh.14844.
    PubMed     Abstract available

  42. CHEN MJ, Fang YJ, Wu MS, Chen CC, et al
    Application of Helicobacter pylori stool antigen test to survey the updated prevalence of H. pylori infection in Taiwan.
    J Gastroenterol Hepatol. 2019 Aug 13. doi: 10.1111/jgh.14828.
    PubMed     Abstract available

  43. TANAKA S, Toyonaga T, Kawara F, Watanabe D, et al
    The novel per-oral endoscopic myotomy method preserving oblique muscle using two penetrating vessels as anatomic landmarks reduces postoperative gastroesophageal reflux.
    J Gastroenterol Hepatol. 2019 Aug 1. doi: 10.1111/jgh.14814.
    PubMed     Abstract available

    July 2019
  44. SARKESHIKIAN SS, Ghadir MR, Alemi F, Jalali SM, et al
    Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial.
    J Gastroenterol Hepatol. 2019 Jul 29. doi: 10.1111/jgh.14810.
    PubMed     Abstract available

  45. HUSSAIN S, Singh A, Zameer S, Jamali MC, et al
    No association between proton pump inhibitors use and risk of dementia: Evidence from a meta-analysis.
    J Gastroenterol Hepatol. 2019 Jul 23. doi: 10.1111/jgh.14789.
    PubMed     Abstract available

  46. SIVANES S, Chang J
    Gastrointestinal: A rare cause of upper gastrointestinal bleeding: Epiphrenic esophageal diverticula.
    J Gastroenterol Hepatol. 2019 Jul 4. doi: 10.1111/jgh.14755.

  47. DEGUCHI H, Yamazaki H, Yamamoto Y, Fukuhara S, et al
    Association between parental history of Helicobacter pylori treatment failure and treatment failure in the offspring.
    J Gastroenterol Hepatol. 2019 Jul 1. doi: 10.1111/jgh.14774.
    PubMed     Abstract available

    June 2019
  48. JIANG K, Jiang X, Wen Y, Liao L, et al
    Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis.
    J Gastroenterol Hepatol. 2019 Jun 17. doi: 10.1111/jgh.14759.
    PubMed     Abstract available

    May 2019
  49. PARK SK, Nam JH, Lee H, Chung H, et al
    Beyond uncertainty: negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    J Gastroenterol Hepatol. 2019 May 30. doi: 10.1111/jgh.14745.
    PubMed     Abstract available

  50. HSU PI, Pan CY, Kao JY, Tsay FW, et al
    Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
    J Gastroenterol Hepatol. 2019 May 22. doi: 10.1111/jgh.14736.
    PubMed     Abstract available

  51. ADACHI K, Notsu T, Mishiro T, Kinoshita Y, et al
    Long-term effect of Helicobacter pylori eradication on prevalence of reflux esophagitis.
    J Gastroenterol Hepatol. 2019 May 21. doi: 10.1111/jgh.14730.
    PubMed     Abstract available

  52. YORITA N, Ito M, Boda T, Kotachi T, et al
    Potential of Helicobacter pylori-uninfected signet ring cell carcinoma to invade the submucosal layer.
    J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14706.
    PubMed     Abstract available

    April 2019
  53. WONG SH, Sung JJ
    When repeated Helicobacter pylori therapies fail, what should we do?
    J Gastroenterol Hepatol. 2019;34:627-628.

    March 2019
  54. PITTAYANON R, Piyachaturawat P, Rerknimitr R, Prueksapanich P, et al
    Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial.
    J Gastroenterol Hepatol. 2019 Mar 28. doi: 10.1111/jgh.14671.
    PubMed     Abstract available

  55. MIYAZAKI H, Igarashi A, Takeuchi T, Teng L, et al
    Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: a systematic review.
    J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14664.
    PubMed     Abstract available

  56. FOUAD TR, Abdelsameea E, Abdel-Razek W, Attia A, et al
    Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post-therapeutic outcome and prognostic indicators.
    J Gastroenterol Hepatol. 2019 Mar 14. doi: 10.1111/jgh.14659.
    PubMed     Abstract available

  57. WONG MW, Bair MJ, Chang WC, Hsu CS, et al
    Clinical and psychological characteristics in GERD patients overlapping with laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2019 Mar 8. doi: 10.1111/jgh.14651.
    PubMed     Abstract available

    February 2019
  58. CHOI YK, Ahn JY, Won SH, Jung K, et al
    Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study.
    J Gastroenterol Hepatol. 2019 Feb 27. doi: 10.1111/jgh.14639.
    PubMed     Abstract available

  59. LIOU TC, Liao PH, Lin YC, Chu CH, et al
    Intraluminal therapy for Helicobacter pylori infection.
    J Gastroenterol Hepatol. 2019 Feb 8. doi: 10.1111/jgh.14627.
    PubMed     Abstract available

  60. LEE JW, Kim N, Nam RH, Lee SM, et al
    Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2019 Feb 6. doi: 10.1111/jgh.14625.
    PubMed     Abstract available

  61. HASHIMOTO R, Matsuda T
    Gastrointestinal: Endoscopic findings of monomorphic epitheliotropic intestinal T-cell lymphoma.
    J Gastroenterol Hepatol. 2019;34:311.

  62. MATSUMOTO Y, Ota K, Yamada H
    Gastrointestinal: Intestinal Behcet's disease-like ulcers associated with myelodysplastic syndrome with monosomy 7.
    J Gastroenterol Hepatol. 2019;34:310.

    January 2019
  63. CHAN JSH, Chao ACW, Cheung VCH, Wong SSK, et al
    Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014.
    J Gastroenterol Hepatol. 2019;34:124-131.
    PubMed     Abstract available

    December 2018
  64. WANG KY, Chen YW, Wang TN, Hsu WH, et al
    Predictor of Slower Gastric Emptying in Gastroesophageal Reflux Disease-Survey of An Asian-Pacific Cohort.
    J Gastroenterol Hepatol. 2018 Dec 14. doi: 10.1111/jgh.14572.
    PubMed     Abstract available

  65. Retraction: Usefulness of Helicobacter pylori eradication for precancerous lesions of the gastric remnant.
    J Gastroenterol Hepatol. 2018;33:2055.

    November 2018
  66. ZHENG W, Jiang L, Jia X, Long G, et al
    Analysis of risk factors and development of scoring system to predict severity of upper gastrointestinal bleeding in children.
    J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14548.
    PubMed     Abstract available

  67. SARRI GL, Grigg SE, Yeomans ND
    Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysis.
    J Gastroenterol Hepatol. 2018 Nov 8. doi: 10.1111/jgh.14539.
    PubMed     Abstract available

    August 2018
  68. YEO YH, Hsu CC, Lee CC, Ho HJ, et al
    Systematic review with network meta-analysis: Effectiveness of therapies for second-line Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2018 Aug 31. doi: 10.1111/jgh.14462.
    PubMed     Abstract available

  69. SUE S, Shibata W, Sasaki T, Kaneko H, et al
    Randomized Trial of Vonoprazan- Versus PPI-Based Third-Line Triple Therapy With Sitafloxacin for Helicobacter pylori.
    J Gastroenterol Hepatol. 2018 Aug 27. doi: 10.1111/jgh.14456.
    PubMed     Abstract available

  70. WU SC, Chen WT, Muo CH, Hsu CY, et al
    A comparative study of subsequent liver cirrhosis risk in non- helicobacter pylori infected peptic ulcer patients with and without vagotomy: an Asian population cohort study.
    J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14440.
    PubMed     Abstract available

  71. MOURAD FH, Leong RW
    Role of hemostatic powders in the management of lower gastrointestinal bleeding: A review.
    J Gastroenterol Hepatol. 2018;33:1445-1453.
    PubMed     Abstract available

    July 2018
  72. CHO JH, Jeon SR, Kim HG, Jin SY, et al
    Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.
    J Gastroenterol Hepatol. 2018 Jul 16. doi: 10.1111/jgh.14383.
    PubMed     Abstract available

    June 2018
  73. ADACHI K, Notsu T, Mishiro T, Yoshikawa H, et al
    Influence of Helicobacter pylori infection on periodontitis.
    J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1111/jgh.14358.
    PubMed     Abstract available

    May 2018
  74. AUESOMWANG C, Maneerattanaporn M, Chey WD, Kiratisin P, et al
    Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2018 May 27. doi: 10.1111/jgh.14292.
    PubMed     Abstract available

  75. MIN YW, Kim Y, Gwak GY, Gu S, et al
    Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.
    J Gastroenterol Hepatol. 2018;33:1053-1058.
    PubMed     Abstract available

    March 2018
  76. LU B, Zhang L, Wang J, Wang B, et al
    Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: a survey of Chinese patients (the ENLIGHT Study).
    J Gastroenterol Hepatol. 2018 Mar 25. doi: 10.1111/jgh.14143.
    PubMed     Abstract available

  77. CHOWDHRY M, Shah K, Kemper S, Zekan D, et al
    Proton pump inhibitors are not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    J Gastroenterol Hepatol. 2018 Mar 7. doi: 10.1111/jgh.14141.
    PubMed     Abstract available

  78. GOH KL
    Lessons Learnt from the Epidemiology of Helicobacter Pylori Infection in Malaysia Jghf Marshall and Warren Lecture 2017.
    J Gastroenterol Hepatol. 2018 Mar 2. doi: 10.1111/jgh.14131.
    PubMed     Abstract available

  79. OKANO A, Ohana M
    Gastrointestinal: Improvement of refractory oral ulcer of Behcet's disease after eradication of Helicobacter pylori.
    J Gastroenterol Hepatol. 2018;33:560.

    February 2018
  80. PARK JC, Kim YJ, Kim EH, Lee J, et al
    Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding: using propensity score matching.
    J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14118.
    PubMed     Abstract available

    January 2018
    J Gastroenterol Hepatol. 2018 Jan 10. doi: 10.1111/jgh.14090.
    PubMed     Abstract available

    December 2017
  82. TAKAHASHI Y, Takeuchi T, Kojima Y, Nagami Y, et al
    Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.
    J Gastroenterol Hepatol. 2017 Dec 19. doi: 10.1111/jgh.14073.
    PubMed     Abstract available

  83. MA J, Hiratsuka T, Etoh T, Akada J, et al
    Anti-proliferation effect of blue light-emitting diodes against antibiotic-resistant Helicobacter pylori.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14066.
    PubMed     Abstract available

    November 2017
  84. XU MY, Ma JH, Yuan BS, Yin J, et al
    Association between helicobacter pylori infection and gallbladder diseases: a retrospective study.
    J Gastroenterol Hepatol. 2017 Nov 27. doi: 10.1111/jgh.14054.
    PubMed     Abstract available

  85. MISHIRO T, Oka K, Kuroki Y, Takahashi M, et al
    Proton pump inhibitor alters oral microbiome in gastrointestinal tract of healthy volunteers.
    J Gastroenterol Hepatol. 2017 Nov 4. doi: 10.1111/jgh.14040.
    PubMed     Abstract available

  86. KIM GU, Seo M, Song EM, Hwang SW, et al
    Association between the ulcer status and the risk of delayed bleeding after the endoscopic mucosal resection of colon.
    J Gastroenterol Hepatol. 2017;32:1846-1851.
    PubMed     Abstract available

    September 2017
  87. MANABE N, Haruma K, Kusunoki H, Kamada T, et al
    Differences in Salivary Secretory Function between Patients with Erosive Esophagitis and Those with Nonerosive Reflux Disease.
    J Gastroenterol Hepatol. 2017 Sep 27. doi: 10.1111/jgh.14002.
    PubMed     Abstract available

    July 2017
  88. MIN S, Kim N, Kwon YH, Hee R, et al
    RdxA, frxA and efflux pump in metronidazole-resistant Helicobacter pylori: their relation to clinical outcomes.
    J Gastroenterol Hepatol. 2017 Jul 27. doi: 10.1111/jgh.13906.
    PubMed     Abstract available

  89. AGARWAL J, Hasan A, Mehrotra M
    Hepatobiliary and Pancreatic: Hepatogastric fistula.
    J Gastroenterol Hepatol. 2017;32:1284.

    May 2017
  90. YANG EH, Cheng HC, Wu CT, Chen WY, et al
    Peptic ulcer bleeding patients with Rockall Scores >/= 6 are at risk of long-term ulcer rebleeding: a 3.5-year prospective longitudinal study.
    J Gastroenterol Hepatol. 2017 May 11. doi: 10.1111/jgh.13822.
    PubMed     Abstract available

  91. KIM JH, Lim KS, Min YW, Lee H, et al
    Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    J Gastroenterol Hepatol. 2017;32:1064-1070.
    PubMed     Abstract available

    January 2017
  92. BATCHELOR R, Gilmartin JF, Kemp W, Hopper I, et al
    Dementia, cognitive impairment and proton pump inhibitor therapy - a systematic review.
    J Gastroenterol Hepatol. 2017 Jan 27. doi: 10.1111/jgh.13750.
    PubMed     Abstract available

  93. EUSEBI LH, Rabitti S, Artesiani ML, Gelli D, et al
    J Gastroenterol Hepatol. 2017 Jan 16. doi: 10.1111/jgh.13737.
    PubMed     Abstract available

  94. LEE YC, Lin JT
    Screening and Treating Helicobacter pylori Infection for Gastric Cancer Prevention on the Population Level.
    J Gastroenterol Hepatol. 2017 Jan 14. doi: 10.1111/jgh.13726.
    PubMed     Abstract available

  95. GONG EJ, Choi KD, Jung HK, Youn YH, et al
    Quality of life, patient satisfaction, and disease burden in patients with gastroesophageal reflux disease with or without laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2017 Jan 3. doi: 10.1111/jgh.13716.
    PubMed     Abstract available

  96. KONO Y, Kawano S, Takaki A, Shimomura Y, et al
    Oxidative stress controlling agents are effective for small intestinal injuries induced by non-steroidal anti-inflammatory drugs.
    J Gastroenterol Hepatol. 2017;32:136-145.
    PubMed     Abstract available

    December 2016
  97. ZOU D, Goh KL
    An East Asian Perspective on the Interaction between Proton Pump Inhibitors and Clopidogrel.
    J Gastroenterol Hepatol. 2016 Dec 26. doi: 10.1111/jgh.13712.
    PubMed     Abstract available

    November 2016
  98. ON ZX, Grant J, Shi Z, Taylor AW, et al
    The association between gastroesophageal reflux disease (GERD) with sleep quality, depression and anxiety in a cohort study of Australian men.
    J Gastroenterol Hepatol. 2016 Nov 11. doi: 10.1111/jgh.13650.
    PubMed     Abstract available

    October 2016
  99. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
    Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
    PubMed     Abstract available

    September 2016
  100. JUNG SW, Kim SY, Choe JW, Hyun JJ, et al
    Standard and double dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection.
    J Gastroenterol Hepatol. 2016 Sep 16. doi: 10.1111/jgh.13597.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.